UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stock Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lowered its stake in shares of Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 54.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 526,073 shares of the company's stock after selling 632,317 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.24% of Bath & Body Works worth $20,396,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of BBWI. SRS Capital Advisors Inc. increased its position in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company's stock valued at $26,000 after acquiring an additional 329 shares during the last quarter. Golden State Wealth Management LLC bought a new position in Bath & Body Works during the fourth quarter valued at $26,000. Lindbrook Capital LLC increased its position in Bath & Body Works by 81.9% during the fourth quarter. Lindbrook Capital LLC now owns 957 shares of the company's stock valued at $37,000 after acquiring an additional 431 shares during the last quarter. Smartleaf Asset Management LLC increased its position in Bath & Body Works by 135.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,013 shares of the company's stock valued at $39,000 after acquiring an additional 582 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its position in Bath & Body Works by 109.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 1,629 shares of the company's stock valued at $63,000 after acquiring an additional 852 shares during the last quarter. Institutional investors own 95.14% of the company's stock.

Bath & Body Works Trading Down 1.5%

Bath & Body Works stock traded down $0.42 during mid-day trading on Friday, hitting $28.16. The company had a trading volume of 6,154,657 shares, compared to its average volume of 5,000,590. Bath & Body Works, Inc. has a 12-month low of $24.96 and a 12-month high of $52.99. The company's fifty day moving average is $30.07 and its 200-day moving average is $33.97. The company has a market capitalization of $6.00 billion, a price-to-earnings ratio of 6.87, a P/E/G ratio of 0.92 and a beta of 1.87.

Bath & Body Works (NYSE:BBWI - Get Free Report) last announced its earnings results on Thursday, May 29th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.47 by $0.02. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The firm had revenue of $1.40 billion for the quarter, compared to analyst estimates of $1.42 billion. During the same quarter last year, the firm posted $0.38 EPS. The business's revenue was up 2.9% on a year-over-year basis. As a group, sell-side analysts expect that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works declared that its board has approved a stock repurchase program on Thursday, February 27th that authorizes the company to buyback $500.00 million in outstanding shares. This buyback authorization authorizes the company to buy up to 6.4% of its stock through open market purchases. Stock buyback programs are often an indication that the company's leadership believes its shares are undervalued.

Bath & Body Works Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Stockholders of record on Friday, June 6th will be issued a dividend of $0.20 per share. The ex-dividend date is Friday, June 6th. This represents a $0.80 annualized dividend and a dividend yield of 2.84%. Bath & Body Works's dividend payout ratio is presently 21.33%.

Analyst Ratings Changes

A number of analysts have recently issued reports on BBWI shares. Robert W. Baird boosted their target price on shares of Bath & Body Works from $45.00 to $47.00 and gave the company an "outperform" rating in a research note on Friday, February 28th. Telsey Advisory Group reiterated an "outperform" rating and issued a $38.00 target price (down from $43.00) on shares of Bath & Body Works in a report on Thursday. Barclays reduced their target price on shares of Bath & Body Works from $35.00 to $30.00 and set an "equal weight" rating for the company in a report on Friday. Cowen restated a "buy" rating on shares of Bath & Body Works in a report on Thursday, February 27th. Finally, Piper Sandler set a $39.00 price objective on shares of Bath & Body Works and gave the company an "overweight" rating in a report on Thursday, May 15th. Four investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $42.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.